ArticleClinical case reports2021
SARS-CoV-2 and guttate psoriasis: A case report and review of literature.
Article in Clinical case reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- SARS-CoV-2 and chronic myeloid leukemia: a systematic review.Frontiers in medicine · 2023Pooled it
- Management of Guttate Psoriasis: A Systematic Review.Journal of cutaneous medicine and surgeryPooled it
- Rapid resolution of guttate psoriasis with upadacitinib: a case report.Frontiers in medicine · 2026Article
- Article
- Childhood guttate psoriasis: an updated review.Drugs in context · 2023Review
- Hyponatremia and SARS-CoV-2 infection: A narrative review.Medicine · 2022Review
- The Impact of COVID-19 Pandemic on Dermatological Conditions: A Novel, Comprehensive Review.Dermatopathology (Basel, Switzerland) · 2022Review
- SARS-CoV-2 omicron variant may present with severe sickle cell painful crisis: A report of two cases.Clinical case reports · 2022Article
- A case series of early biologic therapy in guttate psoriasis: Targeting resident memory T cell activity as a potential novel therapeutic modality.JAAD case reports · 2022Article
- Article
- SARS-CoV-2 Omicron Variant in Patients With Chronic Myeloid Leukemia: A Retrospective Study.Cureus · 2022Article
- Outpatient Management of COVID-19: A Primer for the Dermatologist.Current dermatology reports · 2022Review
- SARS-CoV-2 and guttate psoriasis: A case report and review of literature.Clinical case reports · 2021Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Guttate psoriasis is a rare dermatological presentation of SARS-CoV-2 infection and is seen mainly in patients with an underlying disease psoriasis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.